Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > BioNTech
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(95)
•••
Comment by gojotv!on Mar 22, 2021 5:58pm
177 Views
Post# 32855175

RE:RE:RE:RE:RE:BioNTech

RE:RE:RE:RE:RE:BioNTech
  1. You misunderstand me, charlierock.
I don't want Big Pharma to "pay". I want them to get lost. I'd much rather pocket the $1-2000/share AFTER A FEW STOCK SPLITS and subsequent dividends myself!!
...As I watch the kids get great-paying tech jobs in a nice, clean, Canadian Pharma-Tech Corp!
Anyone willing to sell this to a "Pig" Pharma so they can shelve it or distort it or replace it with more expensive, painful and invasive immunotherapy is either:
  1. Allergic to money, or
  2. In love with the idea of having their upcoming cancers treated with long, painful hospital procedures and convalescence.
Me? ... No.... Thanks.
I want the QUAN!
Of course, if you're not willing to hold for an extra year or so to get the QUAN, feel free to set yourself a price and sell when it hits.
Because it will hit.
And I want to share this health and prosperity with my whole community. GQTA!


charlierock wrote: gojo I have to agree. No big pharmaceutical company is going to want to take us out at least until the technology is proven beyond a shadow of a doubt. If they want this company it's gonna cost them. Once we get positive data it will be much more Justifiable on their part to entertain the idea and by then TLTS stock price will be much higher. They have very deep pockets and they will pay.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities